These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38494667)

  • 1. Clinical outcomes and risk factors for immune recovery and all-cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study.
    Castillo-Rozas G; Tu S; Luz PM; Mejia F; Sierra-Madero J; Rouzier V; Shepherd BE; Cortes CP
    J Int AIDS Soc; 2024 Mar; 27(3):e26214. PubMed ID: 38494667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dolutegravir based therapy showed CD4
    Gebremedhin T; Aynalem M; Adem M; Geremew D; Aleka Y; Kiflie A
    Sci Rep; 2024 Feb; 14(1):3297. PubMed ID: 38331983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal immune recovery and associated factors among people living with HIV/AIDS on second-line antiretroviral therapy in central China: A retrospective cohort study.
    Zhu K; Xu Q; Ma Y; Li P; Jia H; Jiang Q; Wang Y; Wu Z; Wang D; Guo H; Jin Y
    J Med Virol; 2022 Oct; 94(10):4975-4982. PubMed ID: 35710693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of first-line antiretroviral therapy in Latin America: analysis from the LATINA retrospective cohort study.
    Angriman F; Belloso WH; Sierra-Madero J; Sánchez J; Moreira RI; Kovalevski LO; Orellana LC; Cardoso SW; Crabtree-Ramirez B; La Rosa A; Losso MH
    Int J STD AIDS; 2016 Feb; 27(2):118-26. PubMed ID: 25740759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
    Silveira MP; Silveira CP; Guttier MC; Page K; Moreira LB
    J Clin Pharm Ther; 2016 Dec; 41(6):689-694. PubMed ID: 27676134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.
    Arici C; Ripamonti D; Ravasio V; Maggiolo F; Rizzi M; Finazzi MG; Suter F
    Int J STD AIDS; 2001 Sep; 12(9):573-81. PubMed ID: 11516366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
    Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
    Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival, CD4 T lymphocyte count recovery and immune reconstitution pattern during the first-line combination antiretroviral therapy in patients with HIV-1 infection in Mongolia.
    Bayarsaikhan S; Jagdagsuren D; Gunchin B; Sandag T
    PLoS One; 2021; 16(3):e0247929. PubMed ID: 33684169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study.
    Bahemana E; Esber A; Dear N; Ganesan K; Parikh A; Reed D; Maganga L; Khamadi S; Mizinduko M; Lwilla A; Mkondoo D; Mwaisanga G; Somi N; Owouth J; Maswai J; Kiweewa F; Iroezindu M; Ake JA; Crowell TA; Valcour VG; Polyak CS;
    AIDS Res Ther; 2020 Nov; 17(1):66. PubMed ID: 33183355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults.
    Fiseha T; Ebrahim H; Ebrahim E; Gebreweld A
    PLoS One; 2022; 17(3):e0265740. PubMed ID: 35324948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes.
    Hsu RK; Fusco JS; Henegar CE; Vannappagari V; Clark A; Brunet L; Lackey PC; Pierone G; Fusco GP
    BMC Infect Dis; 2023 Feb; 23(1):91. PubMed ID: 36782125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
    Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.
    Zhao Y; Wu Z; McGoogan JM; Shi CX; Li A; Dou Z; Ma Y; Qin Q; Brookmeyer R; Detels R; Montaner JSG
    Clin Infect Dis; 2018 Feb; 66(5):727-734. PubMed ID: 29069362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.
    Cesar C; Jenkins CA; Shepherd BE; Padgett D; Mejía F; Ribeiro SR; Cortes CP; Pape JW; Madero JS; Fink V; Sued O; McGowan C; Cahn P;
    Lancet HIV; 2015 Nov; 2(11):e492-500. PubMed ID: 26520929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV treatment outcomes among people who acquired HIV via injecting drug use in the Asia-Pacific region: a longitudinal cohort study.
    Han WM; Jiamsakul A; Salleh NAM; Choi JY; Huy BV; Yunihastuti E; Do CD; Merati TP; Gani YM; Kiertiburanakul S; Zhang F; Chan YJ; Lee MP; Chaiwarith R; Ng OT; Khusuwan S; Ditangco R; Kumarasamy N; Sangle S; Ross J; Avihingsanon A;
    J Int AIDS Soc; 2021 May; 24(5):e25736. PubMed ID: 34021711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China.
    Bai R; Lv S; Hua W; Su B; Wang S; Shao Y; Li Z; Liu A; Sun L; Dai L
    HIV Med; 2022 Mar; 23 Suppl 1():72-83. PubMed ID: 35293102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
    Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.